Technology Transfer for the Max Planck Society

Max Planck Innovation is responsible for technology transfer from the research institutes of the Max Planck Society.

The Max Planck Society (MPG) operates as Germany’s most successful organization in basic research and is worldrenowned for its cutting-edge research. In many cases this cutting-edge research also forms the basis for innovative products and services that are implemented through licensing and spin-off companies.

Thus we perform an important task: the transfer of basic research results into products, which contribute to the economic and social progress.

50 years of Max Planck innovation - 50 years of technology transfer for the Max Planck Society

Max Planck Innovation celebrates its 50th anniversary. On this occasion, MaxPlanckResearch reports on success stories, researchers and founders, companies, perspectives and the path from ideas to products.

eMagazine

Download as PDF (6,9 MB)

We are your contact for

Invention

We advise and support scientists in the evaluation and patenting of research results while helping to establish the best success in the market.

More

Foundation

Do you have a business idea? If so, talk to us! We offer founders a comprehensive range of services from evaluating a spin-off project through to fundraising support.

More

Industry

We provide future-oriented companies with access to the patented inventions and know-how of the Max Planck Institutes and offer them licensing opportunities.

More

Technology Offers

Sensors, Devices & Components

Multifunctional RFID-based Platform for Animal Observation and Manipulation

Go to techoffer

New Materials

Bioinspired Liquid-Superrepellent Fibrillar Dry Adhesives

Go to techoffer

Analytics

Novel method for analysis of complex carbohydrate structures by ion-mobility mass spectrometry (IM-MS)

Go to techoffer

IT / Software / Bioinformatics

Novel protein expression optimization method combining machine learning with insights from mechanistic modelling of mRNA translation

Go to techoffer

Processes and Methods

High-precision base editors for site-specific single nucleotide conversion

Go to techoffer

Medicine

First in class “semi-live” RNA vaccines against SARS-CoV-2, RSV and other respiratory viruses

Go to techoffer

Research Tools

A novel type of influenza A virus-derived Defective interfering Particle for antiviral therapy

Go to techoffer

Imaging & Microscopy

Method for the Calibration of a Microscope Setup

Go to techoffer

News

Press release

225 million euros for Max Planck innovation start-ups

The successful business year for Max Planck Innovation includes increasing investment amounts for the start-ups supported.

More

 

News

Yearbook 2022 Max Planck Innovation

Successes, licences & start-ups

More

 

Press release

New research project aims to accelerate screening for active pharmaceutical ingredients

Over 11 million euros funding

More

 

Press release

Clemedi AG concludes license agreement for detecting latent tuberculosis

New diagnostic tool aims to improve disease management

More

 

News

50+2 years of technology transfer for the Max Planck Society

The technology transfer organization of the MPG celebrates its anniversary in Berlin

More

 

Press release

Bayer Acquires Targenomix

Targenomix, a spin-off of the Max Planck Institute for Molecular Plant Physiology, will contribute to Bayer’s R&D pipeline

More

 

Press release

A Max Planck spin-off develops more powerful and resource-saving batteries

Batene GmbH starts with ten million euros in seed financing

More

 

Press release

Start-up CalTIC secures up to EUR 3 million in seed financing to develop a new class of drugs targeting TRPC channels

Newly founded spin-off brings hope for patients suffering from metabolic diseases, obesity, and heart hypertrophy

More

 

Newsletter Sign up

Sign up for our newsletter and our press releases and receive the latest information on technology transfer from the Max Planck Society: Sign up